Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Xyf source : Www.biospace.com save search
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
Published: 2024-04-10 (Crawled : 12:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: -2.11%
H: 2.96%
C: 2.15%
CSTL | $19.28 0.42% 0.41% 130K
|
Health Technology
|
| O: -1.76%
H: 0.0%
C: 0.0%
year for financial
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
Published: 2024-02-02 (Crawled : 14:30) - biospace.com/
RYZB | $62.49 0.03% 280K
|
|
| O: 0.03%
H: 0.11%
C: 0.0%
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 1.04%
H: 1.79%
C: -1.23%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.23%
H: 1.5%
C: -1.14%
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
financial results
Alternative Funding Strategies to Discuss at JPM
Published: 2024-01-05 (Crawled : 13:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: -3.44%
H: 4.3%
C: 1.14%
funding alternative
Alternative Funding Strategies to Discuss at JPM
Published: 2024-01-04 (Crawled : 15:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 1.52%
H: 6.75%
C: 6.75%
funding alternative
Alternative Funding Strategies to Discuss at JPM
Published: 2023-12-22 (Crawled : 19:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 0.27%
H: 3.22%
C: -0.54%
funding alternative
Alternative Funding Strategies to Discuss at JPM
Published: 2023-12-13 (Crawled : 15:30) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 0.0%
H: 4.47%
C: 0.84%
funding alternative
Eikon Therapeutics Announces the Election of Robert L. Huffines to its Board of Directors
Published: 2023-12-04 (Crawled : 13:30) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: -2.08%
H: 0.0%
C: -6.6%
therapeutics
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
Published: 2023-10-26 (Crawled : 13:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: -3.19%
H: 4.87%
C: 4.87%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -4.68%
H: 2.46%
C: -1.83%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 0.16%
H: 0.47%
C: 0.2%
financial results
ImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial Officer
Published: 2023-09-18 (Crawled : 13:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: -4.32%
H: 2.61%
C: -0.71%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: -1.08%
H: 1.99%
C: 1.03%
financial
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
Published: 2023-07-27 (Crawled : 13:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: -1.34%
H: 1.36%
C: 1.36%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -3.21%
H: 2.51%
C: -0.44%
financial results
Abivax Releases the Results of its June 5, 2023 Ordinary and Extraordinary General Meeting
Published: 2023-06-08 (Crawled : 15:20) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 4.42%
H: 0.75%
C: 0.5%
meeting results
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
Published: 2023-04-27 (Crawled : 12:20) - biospace.com/
TSVT | $4.52 -2.59% -2.65% 610K
|
|
| O: 0.71%
H: 8.58%
C: 5.64%
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: -3.13%
H: 3.23%
C: 1.94%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.17%
H: 0.31%
C: 0.06%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.6%
financial results
Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 Process
Published: 2023-03-27 (Crawled : 13:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: -3.08%
H: 4.24%
C: 3.18%
CDAK | $0.057 -55.99% -131.25% 0
|
Health Technology
|
| O: -64.05%
H: 59.08%
C: 18.84%
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2022
Published: 2023-02-02 (Crawled : 13:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: -0.49%
H: 0.0%
C: -4.69%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -1.28%
H: 3.64%
C: 3.48%
financial
Applied UV Adds Veteran Leader and Banking Executive Jos Luhukay to Board of Directors
Published: 2022-05-24 (Crawled : 13:20) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 2.12%
H: 0.0%
C: 0.0%
AUVI | $0.642 -8.1% -8.82% 120K
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: -11.01%
Protagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President and Chief Financial Officer
Published: 2022-03-28 (Crawled : 12:20) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 3.97%
H: 4.51%
C: -2.43%
PTGX | $25.61 1.55% 1.52% 450K
|
Health Technology
|
| O: 0.2%
H: 0.68%
C: -0.76%
therapeutics
Sheppard Mullin Expands Life Sciences Team With FDA Regulatory Group
Published: 2022-03-09 (Crawled : 21:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 3.91%
H: 1.88%
C: -2.4%
fda life science group
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China
Published: 2022-01-28 (Crawled : 11:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 4.35%
H: 0.0%
C: -4.87%
aup-16 urea gene therapy license therapeutics disease cel one china therapy collaboration diabetic diabetes
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
Published: 2022-01-03 (Crawled : 19:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 1.33%
H: 4.26%
C: 2.62%
at04 affitope license cholesterol immunotherapy china therapy biotech iot hypercholesterolemia
Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process
Published: 2021-10-14 (Crawled : 12:00) - biospace.com/
XYF | $3.78 0.0% 5.6K
|
Finance
|
| O: 2.5%
H: 0.67%
C: -4.88%
sales
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
MPLN | $0.6502 -11.74% 4.51% 2.2M
|
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
OUST 4 | $7.16 2.43% 3.77% 880K
|
Manufacturing
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
DDL | News | $1.15 6.48% 3.48% 200K
|
Retail Trade
PZG | $0.4431 0.48% 2.91% 150K
|
Non-Energy Minerals
LEV | $0.972 0.73% 2.88% 570K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.